Which genotype is most common?
Which genotype is most common?
Hepatitis C virus genotype 1 is the most prevalent genotype and accounts for 83.4 million infections, or 46.2% of all cases, worldwide, according to a study published in Hepatology.
What are the blood genotypes?
Genotypes
| Blood Type | Genotype |
|---|---|
| Blood Type A | Genotypes AA or AO |
| Blood Type B | Genotypes BB or BO |
| Blood Type AB | Genotype AB |
| Blood Type O | Genotype OO |
What is the life expectancy of someone with hep C?
People with hepatitis C can live many years after diagnosis, but the range varies. A 2014 study showed that patients infected with hepatitis C virus died on average 15 years sooner than people who did not have the illness. With hepatitis C, the liver becomes seriously damaged due to inflammation.
What HCV 2?
Genotype 2 (HCV-2) accounts for 8% of the patients with chronic hepatitis C virus in Europe. Because of the favourable response to interferon (IFN)-based treatment, this group is considered an ‘easy-to-treat’ genotype along with HCV-3.
Why is HCV genotype important?
All HCV genotypes cause the same amount of liver damage. However, people infected with genotype 1, particularly subtype 1b, may have a greater chance of developing cirrhosis, or severe liver scarring, than other genotypes. Genotypes 1b and 3 may increase the risk of liver cancer.
What is the normal range for HCV?
Normal range for this assay is “Not Detected”. The quantitative range of this assay is 10 – 100,000,000 IU/mL (1.0 – 8.0 log IU/mL).
How long can you take sofosbuvir for HCV genotype 2?
We randomly assigned 91 patients with HCV genotype 2 infection and 328 with HCV genotype 3 infection, in a 4:1 ratio, to receive sofosbuvir–ribavirin or placebo for 12 weeks.
What are the side effects of sofosbuvir and ribavirin?
The most common adverse events were headache, fatigue, and pruritus. Therapy with sofosbuvir–ribavirin for 12 weeks in patients with HCV genotype 2 infection and for 24 weeks in patients with HCV genotype 3 infection resulted in high rates of sustained virologic response. (Funded by Gilead Sciences; VALENCE ClinicalTrials.gov number, NCT01682720
Which is better HCV genotype 1 or 2?
Historically, in the interferon era, treatment of persons with HCV genotype 2 infection achieved higher sustained virologic response (SVR) rates than those with HCV genotype 1 infection, even with a shorter duration of therapy and lower doses of ribavirin.
Which is the best treatment for genotype 2 Hep C?
Later that year, the United States Food and Drug Administration (FDA) approved a 12-week course with the all-oral regimen of sofosbuvir plus ribavirin for the treatment of genotype 2 infection based on data from several studies showing SVR rates of approximately 92 to 97% with this regimen.
